Physicochemical and genetic evidence for specific antiestrogen binding sites

scientific article published on June 1983

Physicochemical and genetic evidence for specific antiestrogen binding sites is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1983PNAS...80.3158F
P356DOI10.1073/PNAS.80.11.3158
P932PMC publication ID393999
P698PubMed publication ID6574477
P5875ResearchGate publication ID16620791

P2093author name stringE E Baulieu
G Redeuilh
F Bayard
J C Faye
S Jozan
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
Antibodies to estrogen receptor: Immunochemical similarity of estrophilin from various mammalian speciesQ35048365
Estradiol receptor of calf uterus: interactions with heparin-agarose and purificationQ35060551
Estrogen and Antiestrogen Action in Reproductive Tissues and TumorsQ38041110
A method for determining the sedimentation behavior of enzymes: application to protein mixturesQ39512885
Production and detection of antibodies against the estrogen receptor from calf uterine cytosolQ39984511
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.Q41619173
The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue cultureQ42803245
Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cellsQ43411264
Monohydroxytamoxifen: An antioestrogen with high affinity for the chick oviduct oestrogen receptorQ43634735
A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activityQ44004732
Cytoplasmic and nuclear estradiol and progesterone receptors in human endometriumQ45004310
New biospecific adsorbents for the purification of estradiol receptorQ53815622
[Mechanism of action of a triphenylethylene type antiestrogen on growth of the human breast cancer cell line. MCF-7 in culture]Q54537535
Tamoxifen is a potent "pure" anti-oestrogen in chick oviductQ59080823
High-affinity anti-oestrogen binding site distinct from the oestrogen receptorQ59082035
Differential binding of antiestrogens by rat uterine and chick oviduct cytosolQ66979028
High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptorQ67367424
Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogenQ67446195
Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosolQ70650484
Modifications in the aminoether side chain of clomiphene influence affinity for a specific antiestrogen binding site in MCF 7 cells cytosolQ70899616
Calf uterine estradiol receptor. Effects of molybdate on salt-induced transformation process and characterization of a nontransformed receptor stateQ70975881
Inhibition of uterine estrogen receptor transformation by sodium molybdateQ71241824
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metaboliteQ71397987
Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue cultureQ71569150
Properties of a uterine oestradiol receptorQ72093764
P4510describes a project that usesMCF-7/RTx6Q54904377
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectcell lineQ21014462
P304page(s)3158-3162
P577publication date1983-06-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titlePhysicochemical and genetic evidence for specific antiestrogen binding sites
P478volume80

Reverse relations

cites work (P2860)
Q68674574A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues
Q43505469Anti-proliferative effects of 1,2-diphenylethane oestrogens and anti-oestrogens on human breast cancer cells
Q43685275Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites
Q34786218Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy
Q73226598Diphenyl quinolines and isoquinolines: synthesis and primary biological evaluation
Q54393577Estrogen inhibits the growth of MCF-7 cell variants resistant to transforming growth factor-beta.
Q25257588Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways.
Q68581882Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells
Q42150530Interaction of unsaturated fatty acids with anti-oestrogen-binding sites
Q41463841Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer
Q42853991Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization
Q39715988Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle
Q28568639Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site
Q40971042Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity
Q24631017Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture
Q44100624Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors
Q30403555Solubilization of a tamoxifen-binding protein. Assessment of its molecular mass
Q40913236Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor
Q72995250Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS)
Q41979321Unsaturated fatty acids as endogenous inhibitors of tamoxifen binding to anti-oestrogen-binding sites

Q54904377MCF-7/RTx6described by sourceP1343

Search more.